Comorbid infections in patients with spondyloarthritis who received modern antirheumatic therapy (preliminary data)
Actuality. Data on the prevalence of comorbid infections (CI) in patients with spondyloarthritis (SpA) are few. Risk factors for CI has not been sufficiently studied.Objective. To evaluate the frequency of comorbid infections in patients with spondyloarthritis treated with biological drugs in the fo...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2022-09-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/3199 |